|Areas of the Brain Affected by Alzheimer's Disease|
|Copyright © Nucleus Medical Media, Inc.|
- Plaques—Abnormal deposits of a substance called beta amyloid in different areas of the brain
- Neurofibrillary tangles—Twisted fibers (called tau fibers) within the nerve cells
- Previous serious, traumatic brain injury
- Lower educational achievement
- Obesity in middle-age
- Down's syndrome
- Down's syndrome in a first-degree relative
- Women under age 35 who give birth to a child with Down's syndrome
- Family history of Alzheimer's disease
- Presence of a certain type of protein (APOE-e4)
- Elevated levels of homocysteine
- Heart disease
- Early—Loss of memory, reasoning, understanding, or learning, but does not interfere with independence
- Intermediate—Increased mental loss, personality changes, and increased dependence on others for basic needs
- Severe—Loss of personality and bodily functions with total dependence on others for care
Increasing trouble remembering things, such as:
- How to get to familiar locations
- What the names of family and friends are
- Where common objects are usually kept
- How to do simple math
- How to do usual tasks, such as cooking, dressing, and bathing
- Having difficulty concentrating on tasks
- Having difficulty completing sentences due to lost or forgotten words—may progress to complete inability to speak
- Forgetting the date, time of day, or season
- Getting lost in familiar surroundings
- Having mood swings
- Being withdrawn, losing interest in usual activities
- Having personality changes
- Walking in a slow, shuffling way
- Having poor coordination
- Losing purposeful movement
- Blood tests
- Urine tests
- Lumbar puncture
Medications for Symptoms and Disease Progression
- Cholinesterase inhibitors—Recommended for mild-to-moderate Alzheimer's disease
- N-methyl-D-aspartate (NMDA) receptor antagonist—For moderate-to-severe Alzheimer's disease
- Creating an environment in which you can receive the care you need
- Keeping your quality of life as high as possible
- Keeping yourself safe
- Helping yourself learn to deal with the frustration of your uncontrollable behavior
- Providing a calm, quiet, predictable environment
- Providing appropriate eyewear and hearing aids, and easy-to-read clocks and calendars
- Playing quiet music
- Doing light, appropriate exercise to reduce agitation and relieve depression
- Encouraging family and close friends to visit frequently
- Confusion, paranoia, and hallucinations
Alzheimer's Association http://www.alz.org
Alzheimer's Disease Education and Referral Center http://www.nia.nih.gov/alzheimers
Alzheimer Society Canada http://www.alzheimer.ca
Health Canada http://www.hc-sc.gc.ca
Albanese E, Dangour AD, et al. Dietary fish and meat intake and dementia in Latin America, China, and India: a 10/66 Dementia Research Group population-based study. Am J Clin Nutr. 2009;90(2):392-400.
Alzheimer disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated March 31, 2014. Accessed August 18, 2014.
Alzheimer's disease medications fact sheet. National Institute on Aging website. Available at: http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-medications-fact-sheet. Accessed August 18, 2014.
Anstey KJ, Mack HA, et al. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry. 2009;17(7):542-555.
Carillo MC, Blackwell A, et al. Early risk assessment for Alzheimer's disease. Alzheimers dementia. 2009;5(2):182-196.
Deweerdt S. Prevention: activity is the best medicine. Nature. 2011;475:S16-S17.
Gidoni R, et al. Cerebrospinal fluid biomarkers in Alzheimer’s disease: the present and the future. Neurodegen Dis. 2011;8:413-420.
Green RC, Cupples LA, et al. Risk of dementia among white and African-American relatives of patients with Alzheimer disease. JAMA. 2002;287:329-336.
Hampel H, Frank R, et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov. 2010;9:560-574.
Hayden KM, Welsh-Bohmer KA. Epidemiology of cognitive aging and Alzheimer’s disease: contributions of the Cache County Utah study of memory, health, and aging. Curr Top Behav Neurosci. 2011 Aug 2.
Neugroschl J, Sano M. An update on treatment and prevention strategies for Alzheimer’s disease. Curr Neurol Neurosci Rep. 2009;9:368-376.
Ruitenberg A, van Swieten JC, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;359(9303):281-286.
1/8/2010 DynaMed's Systematic Literature Surveillance. Available at: http://www.ebscohost.com/dynamed: Snitz BE, O'Meara ES, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA. 2009;302:2663-2670.
5/4/2012 DynaMed's Systematic Literature Surveillance. Available at: http://www.ebscohost.com/dynamed: Buchman AS, Boyle PA, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78(17):1323-1329.
- Reviewer: Rimas Lukas, MD
- Review Date: 08/2014 -
- Update Date: 08/18/2014 -